Trial Profile
Vancomycin verses Fidaxomicin in clostridium difficile infection recurrence in high risk patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 30 Sep 2016 New trial record